序号 |
标题 |
次数 |
作者 |
发布时间 |
74296 |
Biotin-PEG(4)-MeTz,1962919-31-8,生物素-聚乙二醇(4)-MeTz |
125 |
wyh |
2024-12-23 |
74297 |
DOTAP:DOPC Liposomes,特性与应用 |
132 |
axc |
2024-12-23 |
74298 |
HOOC-PMeOx(50)-N3,26375-28-0,HOCOCH2(C4H7NO)50N3 |
82 |
wyh |
2024-12-23 |
74299 |
Fmoc-Tyr(CH2-Chx)-OH,N-α-(9-芴基甲氧基羰基)-4-环己基甲氧基-L-苯丙氨酸 |
181 |
wyh |
2024-12-23 |
74300 |
cas:1337889-01-6,Ald-Ph-amido-PEG11-C2-NH2 |
83 |
zyl |
2024-12-23 |
74301 |
长链脂肪酸衍生物MAMA-(CH2)17COOH |
114 |
h |
2024-12-23 |
74302 |
cas:1807501-86-5,2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oate |
83 |
zyl |
2024-12-23 |
74303 |
1059189-65-9,m-PEG4-CH2-aldehyde |
82 |
wyh |
2024-12-23 |
74304 |
cas:886209-60-5,perfluorophenyl 2-(cyclooct-2-ynyloxy)acetate |
96 |
zyl |
2024-12-23 |
74305 |
DOOCCH2CH2COOD烷基链试剂 |
102 |
h |
2024-12-23 |
74306 |
cas:1092654-47-1,Azido-PEG3-CH2CO2-NHS |
82 |
wyh |
2024-12-23 |
74307 |
N-芴甲氧羰基-五聚乙二醇-乙酸,Fmoc-NH-PEG5-CH2COOH |
94 |
wyh |
2024-12-23 |
74308 |
cas:1232769-29-7,Mal-CO-PEG5-NHS ester |
121 |
zyl |
2024-12-23 |
74309 |
氨基-PEG4-丁酸,Amino-PEG4-(CH2)3CO2H |
100 |
wyh |
2024-12-23 |
74310 |
cas:1342211-31-7, MC-Val-Ala-OH |
86 |
zyl |
2024-12-23 |
74311 |
cas:150244‐18‐1,sulfo-LC-SPDP |
131 |
zyl |
2024-12-23 |
74312 |
Azido-PEG3-CH2CO2Me,叠氮-三聚乙二醇-CH2CO2甲基 |
163 |
wyh |
2024-12-23 |
74313 |
cas:663598-89-8,1-(4-((5-nitropyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
112 |
zyl |
2024-12-23 |
74314 |
99mTc-HYNIC-PEG4-E[PEG4-c(RGDfk)]2(即99mTc-3PRGD2) |
148 |
wyh |
2024-12-23 |
74315 |
cas:121115-30-8 SPDP-sulfo 2,5-dioxo-1-(3-(pyridin-2-yldisulfanyl)propanoyloxy)pyrrolidine-3-sulfonic acid |
128 |
zyl |
2024-12-23 |
74316 |
MP-PEG8-Val-Ala-PAB-(imp)PBD的组成部分 |
121 |
wyh |
2024-12-23 |
74317 |
perfluorophenyl 3-(2-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)ethoxy)propanoate |
138 |
zyl |
2024-12-23 |
74318 |
MC-Val-Cit-PABC-BF211,抗体药物偶联物(ADCs) |
126 |
wyh |
2024-12-23 |
74319 |
2,3,4,5,6-pentafluorophenyl 3-[2-(2-{2-[(4-formylphenyl)formamido]ethoxy}ethoxy)ethoxy]propanoate |
80 |
zyl |
2024-12-23 |
74320 |
DOPG:DOPC Liposomes,磷脂酰甘油与磷脂酰胆碱脂质体 |
228 |
axc |
2024-12-23 |
74321 |
cas:1353012-00-6,perfluorophenyl 1-azido-3,6,9,12-tetraoxapentadecan-15-oate |
105 |
zyl |
2024-12-23 |
74322 |
1V209-PEG23-TA , 4,7,10-三氧杂-1,13-十三烷二胺和α-甘露糖 |
151 |
wyh |
2024-12-23 |
74323 |
cas:943858-70-6,Azidobutyric acid NHS ester |
98 |
zyl |
2024-12-23 |
74324 |
DOPG Liposomes,磷脂酰甘油脂质体 |
103 |
axc |
2024-12-23 |
74325 |
(64)Cu-NOTA-PEG4-LLP2A的结构组成 |
83 |
wyh |
2024-12-23 |
74326 |
99mTc(CO)3-DPA-DBCO-PEG4-CTT-54的显像效果 |
142 |
wyh |
2024-12-23 |
74327 |
DOPS:DOPC Liposomes,磷脂酰丝氨酸与磷脂酰胆碱脂质体 |
259 |
axc |
2024-12-23 |
74328 |
2,5-dioxopyrrolidin-1-yl 11-oxo-4,7,13-trioxa-10-azahexadec-15-yn-1-oate |
105 |
zyl |
2024-12-23 |
74329 |
DOPC Liposomes,二油酰磷脂酰胆碱脂质体 |
165 |
axc |
2024-12-23 |
74330 |
DTPA(Gd)-PEG8-(FY)3的结构特点 |
101 |
wyh |
2024-12-23 |
74331 |
Fucα1-2Gal-O-(CH2)3-NH-CS-NH-Fluorescein |
103 |
h |
2024-12-23 |
74332 |
DSPC Liposomes,二硬脂酰磷脂酰胆碱脂质体 |
146 |
axc |
2024-12-23 |
74333 |
GlcNAcβ1-3Galβ1-4Glc-O-(CH2)3-NH-Lipoic |
113 |
h |
2024-12-23 |
74334 |
HSPC Liposomes,氢化大豆磷脂酰胆碱脂质体 |
276 |
axc |
2024-12-23 |
74335 |
cas:80307-12-6,GMBS,N-(4-马来酰亚胺丁酰基)琥珀酰亚胺 |
170 |
zyl |
2024-12-23 |
74336 |
DMPC Liposomes,二肉豆蔻酰磷脂酰胆碱脂质体 |
201 |
axc |
2024-12-23 |
74337 |
Galβ1-4GlcNAcβ1-3Gal-O-(CH2)3-NH-DBCO 含DBCO的核心2型丙糖(接头-DBCO A) |
138 |
h |
2024-12-23 |
74338 |
DSPC:Chol Liposomes,二硬脂酰磷脂酰胆碱-胆固醇脂质体 |
359 |
axc |
2024-12-23 |
74339 |
Galβ1-3GlcNAcβ1-3Gal-O-(CH2)3-NH-CS-NH-Fluorescein |
161 |
h |
2024-12-23 |
74340 |
HSPC:Chol Liposomes,磷脂酰丝氨酸-胆固醇脂质体 |
416 |
axc |
2024-12-23 |